Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	38.80	84.24	60.69
Graham Fair Price	58.96	17725.60	11151.13
PEG	-96.62	0.03	-0.84
Price/Book	11.48	0.52	0.47
Price/Cash Flow	-0.08	2.04	-2.04
Prices/Earnings	-56.24	4.38	10.00
Price/Sales	-85.68	1.25	8.74
Price/FCF	-0.08	2.04	-2.04
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	21.67	0.97	0.80
Operating Margin	-90.24	0.09	0.90
ROA	145.01	< 0.005	< 0.005
ROE	0.01	0.03	154.77
ROIC	< 0.005	< 0.005	-13.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.66	-96.50
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.95	-0.24	-87.51
EPS QOQ	-0.12	1.54	1194.61
FCF QOQ	-3.02	2.11	-30.20
Revenue QOQ	-0.02	6.75	28542.10
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	1296.43	242.65	-81.28
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.74	0.74	-0.50
Quick Ratio	1.00	1.21	20.77
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	21757.06	21667.67	-0.41
Cash	20831.32	19049.12	-8.56
Capex	-46.36	-28.71	38.08
Free Cash Flow	-4980.89	5534.40	11.11
Revenue	1162.79	9015.33	675.32
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.00	0.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	51.45	69.99	36.04
Naive Interpretation	Member

06 - Financial Health · Bad

Rating